Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 555,000 | 428,700 | 489,500 | 340,700 | 319,600 |
| Receivables | 1,592,000 | 1,680,700 | 1,523,200 | 1,309,400 | 1,319,900 |
| Inventories | 1,197,000 | 1,171,000 | 1,008,400 | 855,800 | 845,500 |
| Other current assets | 366,000 | 338,100 | 279,900 | 251,200 | 254,900 |
| TOTAL | $3,710,000 | $3,618,500 | $3,301,000 | $2,757,100 | $2,739,900 |
| Non-Current Assets | |||||
| PPE Net | 3,119,000 | 3,015,200 | 2,696,100 | 2,544,100 | 2,647,700 |
| Intangibles | 2,986,000 | 3,116,800 | 2,912,900 | 2,628,900 | 2,724,100 |
| Other Non-Current Assets | 164,000 | 361,500 | 228,000 | 577,000 | 561,200 |
| TOTAL | $6,269,000 | $6,493,500 | $5,837,000 | $5,750,000 | $5,933,000 |
| Total Assets | $9,979,000 | $10,112,000 | $9,138,000 | $8,507,100 | $8,672,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 91,000 | 138,100 | 776,700 | 356,700 | 451,300 |
| Accounts payable and accrued liabilities | 1,061,000 | 1,066,800 | 1,039,700 | 876,100 | 864,400 |
| TOTAL | $2,952,000 | $3,162,700 | $3,469,100 | $2,743,000 | $2,730,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,585,000 | 3,221,900 | 2,720,400 | 2,918,000 | 3,089,500 |
| aiOther Non-Current Liabilities | 1,236,000 | 1,110,100 | 1,227,700 | 941,300 | 1,097,700 |
| TOTAL | $4,983,000 | $4,663,100 | $4,258,000 | $4,414,000 | $4,696,800 |
| Total Liabilities | $7,935,000 | $7,825,800 | $7,727,100 | $7,157,000 | $7,427,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,002,634 | 1,019,642 | 1,026,828 | 1,030,713 | 1,050,430 |
| Common Shares | 733,000 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 11,760,000 | 10,627,500 | 9,643,700 | 8,968,100 | 8,223,900 |
| Other shareholders' equity | -2,543,000 | -1,885,400 | -2,332,500 | -2,088,000 | -2,114,200 |
| TOTAL | $2,044,000 | $2,286,200 | $1,410,900 | $1,350,100 | $1,245,400 |
| Total Liabilities And Equity | $9,979,000 | $10,112,000 | $9,138,000 | $8,507,100 | $8,672,900 |